Table 4.
Marker | Species | Age | Source |
---|---|---|---|
GAD (67/65) | Human | 26 GW – 2 years | Xu et al. 96 |
GAP43 | Human | 14–Newborn PCW | Honig et al. 94 |
13–17 PCW | Bayatti et al. 82 | ||
vGAT | Human | 10 PCW | Bayatti et al. 82 |
KCC2 | Human | 16 PCW | Bayatti et al. 82 |
16 PCW | Wang et al. 83 | ||
MAP2 | Human | 16–22 GW | Sims et al. 97 |
14 PCW–Newborn | Honig et al. 94 | ||
16 PCW | Bayatti et al. 82 | ||
Monkey | E75–160 | Mehra and Hendrickson 84 | |
Synaptojanin | Human | 15–37 GW | Arai et al. 98 |
Synaptophysin | Human | 10 PCW | Bayatti et al. 82 |
NURR1 | Human | 15–22 PCW | Wang et al. 83 |
TBR1 | Human | 9–12 PCW | Bayatti et al. 82 |
α2zinc‐binding globulin | Human | 14 PCW | Wang et al. 83 |
CTGF | Human | 22 PCW | Wang et al. 83 |
Fetuin | Human | 14 PCW | Wang et al. 83 |
24–40 PCW | Elsas et al. 99 | ||
Nogo‐A | Human | 16–36 PCW | Haybaeck et al. 100 |